News

Categories

March 27, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences

March 6, 2024

Zymeworks Reports Fourth Quarter and Full Year 2023 Financial Results

March 5, 2024

Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate and Multispecific Platforms at the American Association for Cancer Research Annual Meeting

February 27, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences

February 14, 2024

Zymeworks To Host Fourth Quarter and Full Year 2023 Results Conference Call

February 8, 2024

Zymeworks Announces Appointment of Dr. Alessandra Cesano to its Board of Directors

January 31, 2024

Zymeworks Announces Participation in Upcoming Investor Conferences

January 4, 2024

Zymeworks Outlines Strategic Priorities and Outlook for 2024 and 2025

January 4, 2024

Zymeworks Announces Additional Leadership Appointments

December 26, 2023

Zymeworks Announces $50 Million Private Placement to EcoR1 Capital

December 15, 2023

Zymeworks Added to Nasdaq Biotechnology Index

November 30, 2023

Zymeworks Announces Participation in Upcoming Investor Conference